The latest closing stock price for SAB Biotherapeutics as of June 06, 2025 is 1.81.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-982 today, roughly -1 times their original investment - a -63.46% compound annual growth rate over 4 years.
The all-time high SAB Biotherapeutics stock closing price was 112.40 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 5.01, which is 176.8% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 1.00, which is 44.8% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 2.58.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-982 today, roughly -1 times their original investment - a -63.46% compound annual growth rate over 4 years.
The all-time high SAB Biotherapeutics stock closing price was 112.40 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 5.01, which is 176.8% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 1.00, which is 44.8% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 2.58.